Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17 | 65 | 48 | N/A | N/A |
| Receivables | 36 | 22 | 15 | N/A | N/A |
| Inventories | 174 | 177 | 177 | N/A | N/A |
| Other current assets | 0 | 15 | 0 | 0 | 0 |
| TOTAL | $258 | $317 | $272 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 32 | 43 | 18 | N/A | N/A |
| Intangibles | 115 | 81 | 36 | 0 | 0 |
| Other Non-Current Assets | 0 | 1 | 12 | 0 | 0 |
| TOTAL | $147 | $125 | $67 | $N/A | $N/A |
| Total Assets | $405 | $443 | $338 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 332 | 184 | 179 | 0 | 0 |
| TOTAL | $600 | $551 | $205 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 65 | 197 | 0 | 0 | 0 |
| TOTAL | $65 | $197 | $N/A | $N/A | $N/A |
| Total Liabilities | $665 | $748 | $205 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,134 | 61,362 | N/A | N/A | N/A |
| Common Shares | 7 | 58 | 52 | N/A | N/A |
| Retained earnings | -4,042 | -2,313 | -1,047 | N/A | N/A |
| Other shareholders' equity | -497 | -10 | -20 | 0 | 0 |
| TOTAL | $-260 | $-305 | $133 | $N/A | $N/A |
| Total Liabilities And Equity | $405 | $443 | $338 | $0 | $0 |